Finance News – Nanoviricides

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Stocks Shares Ceo Tariffs Investors Stock Stock Market Crypto Assets Cryptocurrency Ethereum Price Markets Bse Xrp Etf Stablecoin Investment Blockchain Ipo Eth Index Solana Sec Trade Inflation Earnings Interest Rates Revenue Sensex Token Coinbase Wall Street Treasury Nse Nasdaq Federal Reserve China Traders Bse Sensex Nifty Gold Sp 500 Investor Tesla Profit Economy Company Trading Session Economic Consequences International Emergency Economic Powers Act British Scientists Ark 21shares Bitcoin Etf Us Yields Financial Planning Software Global Infrastructure Partners Eurusd Banking Institutions

Filter by:

Nanoviricides ×

Business Insider Markets • Jul 14, 2025

Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Dr...

The nearing completion of the adaptable treatment protocol for a new antiviral drug in mid-stage trials may impact NanoViricides' future revenue potential and investor confidence.

Read Full Article →